(Q37145913)

English

Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana

scientific article published on June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

Jordan W Tappero

10

object named as

Jordan W Tappero

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Thomas A. Kenyon

8

object named as

Thomas A Kenyon

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Philip C Hopewell

5

object named as

Philip C Hopewell

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Sekai Chideya

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Carla A Winston

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Charles A Peloquin

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

William Z Bradford

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Charles D Wells

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Arthur L Reingold

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Themba L Moeti

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 June 2009

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

48

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1685-1694

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

The diagnosis and therapy of tuberculosis during the past 100 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

The curious characteristics of pyrazinamide: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Tuberculosis therapy: past, present and future.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Low antituberculosis drug concentrations in patients with AIDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

6 September 2017

Clinical pharmacokinetics of the antituberculosis drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

14 September 2017

Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

29 September 2017

Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

29 September 2017

Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

29 September 2017

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

27 June 2018

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

3 September 2018

Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

3 September 2018

Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

3 September 2018

Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

3 September 2018

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3762461

3 September 2018

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of rifampin blood levels in the treatment and follow-up of active pulmonary tuberculosis in patients who were slow to respond to routine directly observed therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19432554

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37145913&oldid=2135637103"